Have your own idea? Try our Stock Screener
Chinese (SSE) Pharma Industry Analysis
UpdatedApr 15, 2025
DataAggregated Company Financials
Companies218
- 7D5.2%
- 3M5.5%
- 1Y4.3%
- YTD4.1%
Over the last 7 days, the Pharma industry has dropped 4.5%, driven by Asymchem Laboratories (Tianjin) declining 6.8%. In contrast, CSPC Innovation Pharmaceutical has gained 22%. This takes the industry's 12 month performance to a gain of 3.1%. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Chinese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Apr 2025 | CN¥2.6t | CN¥802.7b | CN¥77.4b | 27.5x | 33.7x | 3.3x |
| Thu, 13 Mar 2025 | CN¥2.5t | CN¥800.1b | CN¥75.2b | 30.5x | 33.8x | 3.2x |
| Sat, 08 Feb 2025 | CN¥2.5t | CN¥800.2b | CN¥75.6b | 28.2x | 33.1x | 3.1x |
| Mon, 06 Jan 2025 | CN¥2.5t | CN¥799.8b | CN¥75.6b | 28.2x | 32.8x | 3.1x |
| Wed, 04 Dec 2024 | CN¥2.7t | CN¥799.8b | CN¥75.6b | 32.9x | 36.4x | 3.4x |
| Fri, 01 Nov 2024 | CN¥2.6t | CN¥799.6b | CN¥75.5b | 28.8x | 35x | 3.3x |
| Sun, 29 Sep 2024 | CN¥2.5t | CN¥798.6b | CN¥76.3b | 27.9x | 32.7x | 3.1x |
| Tue, 27 Aug 2024 | CN¥2.3t | CN¥804.4b | CN¥78.4b | 25.6x | 29.2x | 2.8x |
| Thu, 25 Jul 2024 | CN¥2.3t | CN¥804.8b | CN¥76.5b | 26.5x | 30x | 2.9x |
| Sat, 22 Jun 2024 | CN¥2.4t | CN¥805.5b | CN¥74.6b | 28x | 32.7x | 3x |
| Mon, 20 May 2024 | CN¥2.8t | CN¥821.7b | CN¥77.5b | 30.4x | 35.5x | 3.3x |
| Wed, 17 Apr 2024 | CN¥2.6t | CN¥828.6b | CN¥80.3b | 25.8x | 31.8x | 3.1x |
| Fri, 15 Mar 2024 | CN¥2.7t | CN¥832.1b | CN¥80.6b | 28.2x | 33x | 3.2x |
| Sun, 11 Feb 2024 | CN¥2.5t | CN¥831.3b | CN¥81.1b | 25x | 30.3x | 3x |
| Tue, 09 Jan 2024 | CN¥2.7t | CN¥830.9b | CN¥79.7b | 30.4x | 33.9x | 3.2x |
| Thu, 07 Dec 2023 | CN¥2.9t | CN¥827.9b | CN¥79.7b | 31.1x | 36x | 3.5x |
| Sat, 04 Nov 2023 | CN¥2.8t | CN¥820.5b | CN¥78.7b | 31.3x | 35.4x | 3.4x |
| Mon, 02 Oct 2023 | CN¥2.8t | CN¥824.9b | CN¥78.6b | 32.3x | 35.8x | 3.4x |
| Wed, 30 Aug 2023 | CN¥2.7t | CN¥820.6b | CN¥78.8b | 30.2x | 33.7x | 3.2x |
| Fri, 28 Jul 2023 | CN¥2.8t | CN¥810.8b | CN¥76.9b | 32.3x | 36.3x | 3.4x |
| Sun, 25 Jun 2023 | CN¥2.8t | CN¥809.7b | CN¥76.5b | 31.3x | 36.4x | 3.4x |
| Tue, 23 May 2023 | CN¥2.9t | CN¥809.1b | CN¥76.5b | 34x | 37.5x | 3.5x |
| Thu, 20 Apr 2023 | CN¥3.0t | CN¥802.4b | CN¥91.1b | 33.5x | 32.8x | 3.7x |
| Sat, 18 Mar 2023 | CN¥2.9t | CN¥782.6b | CN¥84.5b | 36.9x | 34.1x | 3.7x |
| Mon, 13 Feb 2023 | CN¥2.9t | CN¥774.5b | CN¥83.0b | 36.1x | 35.1x | 3.8x |
| Wed, 11 Jan 2023 | CN¥2.8t | CN¥772.3b | CN¥82.1b | 35x | 34.3x | 3.6x |
| Fri, 09 Dec 2022 | CN¥2.9t | CN¥767.8b | CN¥81.9b | 37x | 34.9x | 3.7x |
| Sun, 06 Nov 2022 | CN¥2.7t | CN¥767.3b | CN¥82.0b | 34.4x | 33.3x | 3.6x |
| Tue, 04 Oct 2022 | CN¥2.4t | CN¥760.3b | CN¥79.5b | 30.4x | 30.3x | 3.2x |
| Thu, 01 Sep 2022 | CN¥2.6t | CN¥760.7b | CN¥80.2b | 31.8x | 31.9x | 3.4x |
| Sat, 30 Jul 2022 | CN¥2.6t | CN¥745.2b | CN¥81.0b | 31.2x | 32.2x | 3.5x |
| Mon, 27 Jun 2022 | CN¥2.7t | CN¥739.5b | CN¥81.9b | 32.3x | 33.5x | 3.7x |
| Wed, 25 May 2022 | CN¥2.5t | CN¥740.4b | CN¥81.7b | 31.3x | 30.5x | 3.4x |
| Fri, 22 Apr 2022 | CN¥2.5t | CN¥727.8b | CN¥75.9b | 31.2x | 33x | 3.4x |
Price to Earnings Ratio
33x
Current Industry PE
- Investors are relatively neutral on the Chinese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 33.7x.
- The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 3.3% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 6.38% | |
| Healthcare | 5.17% | |
| Pharma | 5.20% | |
| Pharma | 5.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688506 Sichuan Biokin PharmaceuticalLtd | CN¥259.18 | 14.8% +CN¥13.4b | 117.6% | PE28x | |
| 300765 CSPC Innovation Pharmaceutical | CN¥43.15 | 20.6% +CN¥10.2b | 43.5% | PE1118.5x | |
| 300723 ApicHope Pharmaceutical Group | CN¥39.30 | 44.0% +CN¥5.4b | 81.8% | PS9.3x | |
| 002653 Haisco Pharmaceutical Group | CN¥45.20 | 11.7% +CN¥5.3b | 71.0% | PE126.8x | |
| 002294 Shenzhen Salubris Pharmaceuticals | CN¥35.50 | 12.5% +CN¥4.4b | 23.3% | PE65.8x |